Capricor Therapeutics recently joined PPMD for a community webinar on January 25, 2023 to present recent data findings from the ongoing HOPE-2 open label extension trial and provide an update to the community on the ongoing HOPE-3 clinical trial.
January 31, 2023 /
by: Parent Project Muscular Dystrophy
Capricor Therapeutics recently joined PPMD for a community webinar on January 25, 2023 to present recent data findings from the ongoing HOPE-2 open label extension trial and provide an update to the community on the ongoing HOPE-3 clinical trial.
